Adcock Richard
SEC CIK 1830328 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IBRX | ImmunityBio, Inc. | CEO, Pres, Dir | 637.9K | $17.0K | — | 23 | 2021-09-09 | 2026-02-22 |
Most active insiders at IBRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Simon Barry J. | Dir | — | $4.14M |
| 2 | Selecky Christobel | Dir | — | $3.00M |
| 3 | Cohen Cheryl | Dir | — | $1.25M |
| 4 | Sachs David C. | CFO | — | — |
| 5 | Adcock Richard | CEO, Pres, Dir | — | — |
| 6 | CALIFORNIA CAPITAL EQUITY, LLC | 10% | — | — |
| 7 | LAUER REGAN J | CAO | — | — |
| 8 | SOON-SHIONG PATRICK | See remarks, Dir, 10% | — | — |
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-24 | 2026-02-22 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | M - OptEx | $0.00 | +152.4K | 637.9K | +31% | $0 |
| D | 2026-02-24 | 2026-02-22 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | F - Tax | $8.70 | -77.6K | 560.3K | -12% | -$674.8K |
| D | 2026-02-12 | 2026-02-10 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | M - OptEx | $0.00 | +274.1K | 625.5K | +78% | $0 |
| D | 2026-02-12 | 2026-02-10 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | F - Tax | $6.93 | -140.0K | 485.5K | -22% | -$970.5K |
| D | 2026-01-05 | 2025-12-31 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | F - Tax | $1.98 | -17.5K | 351.4K | -5% | -$34.7K |
| D | 2026-01-05 | 2025-12-31 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | M - OptEx | $0.00 | +34.5K | 368.9K | +10% | $0 |
| D | 2025-02-25 | 2025-02-22 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | M - OptEx | $0.00 | +152.4K | 412.6K | +59% | $0 |
| D | 2025-02-25 | 2025-02-22 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | F - Tax | $3.42 | -78.2K | 334.4K | -19% | -$267.3K |
| D | 2025-01-03 | 2024-12-31 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | M - OptEx | $0.00 | +34.5K | 277.6K | +14% | $0 |
| D | 2025-01-03 | 2024-12-31 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | F - Tax | $2.56 | -17.5K | 260.1K | -6% | -$44.7K |
| D | 2024-02-06 | 2024-02-05 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | F - Tax | $4.04 | -43.2K | 243.1K | -15% | -$174.4K |
| D | 2024-02-06 | 2024-02-05 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | M - OptEx | $0.00 | +83.3K | 286.3K | +41% | $0 |
| D | 2024-01-03 | 2023-12-31 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | M - OptEx | $0.00 | +34.5K | 220.1K | +19% | $0 |
| D | 2024-01-03 | 2023-12-31 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | F - Tax | $5.02 | -17.1K | 203.0K | -8% | -$85.8K |
| D | 2023-02-07 | 2023-02-05 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | M - OptEx | $0.00 | +83.3K | 227.8K | +58% | $0 |
| D | 2023-02-07 | 2023-02-05 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | F - Tax | $4.33 | -42.2K | 185.6K | -19% | -$182.7K |
| D | 2023-01-04 | 2022-12-31 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | F - Tax | $5.07 | -4,273 | 144.4K | -3% | -$21.7K |
| D | 2023-01-04 | 2022-12-31 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | M - OptEx | $0.00 | +8,620 | 148.7K | +6% | $0 |
| D | 2022-02-08 | 2022-02-05 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | M - OptEx | $0.00 | +83.3K | 169.5K | +97% | $0 |
| D | 2022-02-08 | 2022-02-05 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | F - Tax | $5.39 | -29.4K | 140.1K | -17% | -$158.5K |
| MI | 2021-10-08 | 2021-10-08 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Pres, Dir | P - Purchase | $8.81 | +1,930 | 7 | New | +$17.0K |
| D | 2021-09-13 | 2021-09-09 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Dir | M - OptEx | $0.00 | +8,620 | 90.4K | +11% | $0 |
| D | 2021-09-13 | 2021-09-09 | IBRX | ImmunityBio, Inc. | Adcock Richard | CEO, Dir | F - Tax | $9.95 | -4,273 | 86.2K | -5% | -$42.5K |
Purchase Sale Sale after option exercise All abbreviations